Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis

CD20 depletion is a risk factor for unfavorable outcomes of COVID-19 in people with MS (pwMS). Evidence suggests that protective IgG response to mRNA-based vaccines in B cell-depleted individuals is limited. We studied the seroconversion after the third mRNA SARS-CoV-2 vaccine in B cell-depleted pwM...

Descripción completa

Detalles Bibliográficos
Autores principales: Achtnichts, Lutz, Jakopp, Barbara, Oberle, Michael, Nedeltchev, Krassen, Fux, Christoph Andreas, Sellner, Johann, Findling, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707582/
https://www.ncbi.nlm.nih.gov/pubmed/34960216
http://dx.doi.org/10.3390/vaccines9121470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707582/
https://www.ncbi.nlm.nih.gov/pubmed/34960216
http://dx.doi.org/10.3390/vaccines9121470

Ejemplares similares